SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

ROCHE: Click to view the issuer\'s details

Last update : 16/08/2018  >View issuer details

2020.11.24 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche announces FDA approval of Xofluza for the prevention of influenza following contact with an infected person - HTML (w)

2020.11.16 | 07:00 | Permanent Information Releases / General Company News

German version HTML (w) Mail

puce Roche zum elften Mal als nachhaltigstes Gesundheitsunternehmen im Dow Jones Sustainability Index ausgezeichnet - HTML (w)

2020.11.16 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the eleventh time - HTML (w)

2020.11.13 | 17:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza - HTML (w)

2020.11.05 | 15:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting - HTML (w)

2020.10.22 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients - HTML (w)

2020.10.19 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche announces full FDA approval for Venclexta combinations for acute myeloid leukaemia - HTML (w)

2020.10.15 | 07:00 | Permanent Information Releases / General Company News

German version HTML (w) Mail

puce Wachstum von 1% zu konstanten Wechselkursen in den ersten neun Monaten, starker Einfluss der COVID-19-Pandemie - HTML (w)

2020.10.13 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients - HTML (w)

2020.09.28 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche presents new 2-year data for Evrysdi (risdiplam) in infants with Type 1 spinal muscular atrophy (SMA) - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 377